vs
Side-by-side financial comparison of Korro Bio, Inc. (KRRO) and Serve Robotics Inc. (SERV). Click either name above to swap in a different company.
Korro Bio, Inc. is the larger business by last-quarter revenue ($1.3M vs $881.5K, roughly 1.5× Serve Robotics Inc.). On growth, Serve Robotics Inc. posted the faster year-over-year revenue change (400.1% vs -43.1%). Serve Robotics Inc. produced more free cash flow last quarter ($-46.1M vs $-79.1M).
Korro Bio, Inc. is a clinical-stage biotechnology company focused on developing innovative RNA editing therapies for rare and severe genetic diseases. It leverages its proprietary oligonucleotide platform to target disease-causing mutations, with core pipelines covering ophthalmology, respiratory and neuromuscular disorder segments, striving to address unmet medical needs for global patients.
Ecovacs Robotics is a Chinese technology company. It is best known for developing in-home robotic appliances. The company was founded in 1998 by Qian Dongqi and is headquartered in Suzhou, China. According to Global Asia, Ecovacs Robotics had more than 60% of the Chinese market for robots by 2013. In 2023, Nikkei Asia had reported that the market capitalisation of Ecovacs Robotics has grown to near $6.38 billion, which is "roughly 5 times" that of the market capitalisation of rivalling US bas...
KRRO vs SERV — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.3M | $881.5K |
| Net Profit | — | $-34.3M |
| Gross Margin | — | -757.3% |
| Operating Margin | — | -4572.1% |
| Net Margin | — | -3888.1% |
| Revenue YoY | -43.1% | 400.1% |
| Net Profit YoY | -136.1% | -161.3% |
| EPS (diluted) | — | $-0.50 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.3M | $881.5K | ||
| Q3 25 | $1.1M | $687.0K | ||
| Q2 25 | $1.5M | $642.0K | ||
| Q1 25 | $2.5M | $440.5K | ||
| Q4 24 | — | $176.3K | ||
| Q3 24 | $0 | $222.0K | ||
| Q2 24 | $0 | $468.0K | ||
| Q1 24 | $0 | $946.7K |
| Q4 25 | — | $-34.3M | ||
| Q3 25 | $-18.1M | $-33.0M | ||
| Q2 25 | $-25.8M | $-20.9M | ||
| Q1 25 | $-23.4M | $-13.2M | ||
| Q4 24 | — | $-13.1M | ||
| Q3 24 | $-21.0M | $-8.0M | ||
| Q2 24 | $-21.8M | $-9.0M | ||
| Q1 24 | $-19.6M | $-9.0M |
| Q4 25 | — | -757.3% | ||
| Q3 25 | — | -637.4% | ||
| Q2 25 | — | -445.3% | ||
| Q1 25 | — | -333.4% | ||
| Q4 24 | — | -371.7% | ||
| Q3 24 | — | -70.3% | ||
| Q2 24 | — | 30.3% | ||
| Q1 24 | — | 62.8% |
| Q4 25 | — | -4572.1% | ||
| Q3 25 | -1764.9% | -5067.8% | ||
| Q2 25 | -1863.2% | -3527.1% | ||
| Q1 25 | -981.2% | -3406.6% | ||
| Q4 24 | — | -7701.3% | ||
| Q3 24 | — | -3804.1% | ||
| Q2 24 | — | -1828.2% | ||
| Q1 24 | — | -814.6% |
| Q4 25 | — | -3888.1% | ||
| Q3 25 | -1657.0% | -4806.4% | ||
| Q2 25 | -1765.1% | -3247.7% | ||
| Q1 25 | -917.1% | -3000.5% | ||
| Q4 24 | — | -7441.8% | ||
| Q3 24 | — | -3601.8% | ||
| Q2 24 | — | -1931.2% | ||
| Q1 24 | — | -954.7% |
| Q4 25 | — | $-0.50 | ||
| Q3 25 | $-1.92 | $-0.54 | ||
| Q2 25 | $-2.74 | $-0.36 | ||
| Q1 25 | $-2.49 | $-0.23 | ||
| Q4 24 | — | $-0.23 | ||
| Q3 24 | $-2.26 | $-0.20 | ||
| Q2 24 | $-2.43 | $-0.27 | ||
| Q1 24 | $-2.44 | $-0.37 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $75.2M | $106.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $51.4M | $350.7M |
| Total Assets | $113.5M | $367.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $75.2M | $106.2M | ||
| Q3 25 | $92.5M | $116.8M | ||
| Q2 25 | $96.4M | $116.7M | ||
| Q1 25 | $115.0M | $197.8M | ||
| Q4 24 | — | $123.3M | ||
| Q3 24 | $137.0M | $50.9M | ||
| Q2 24 | $157.4M | $28.8M | ||
| Q1 24 | $138.8M | — |
| Q4 25 | $51.4M | $350.7M | ||
| Q3 25 | $99.0M | $283.9M | ||
| Q2 25 | $115.1M | $207.2M | ||
| Q1 25 | $139.0M | $210.2M | ||
| Q4 24 | — | $131.7M | ||
| Q3 24 | $179.6M | $56.2M | ||
| Q2 24 | $198.1M | $28.5M | ||
| Q1 24 | $151.4M | $-8.8M |
| Q4 25 | $113.5M | $367.8M | ||
| Q3 25 | $161.6M | $299.1M | ||
| Q2 25 | $180.4M | $214.3M | ||
| Q1 25 | $202.2M | $216.6M | ||
| Q4 24 | — | $139.6M | ||
| Q3 24 | $243.5M | $61.5M | ||
| Q2 24 | $249.6M | $32.8M | ||
| Q1 24 | $198.0M | $4.2M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-78.6M | $-29.6M |
| Free Cash FlowOCF − Capex | $-79.1M | $-46.1M |
| FCF MarginFCF / Revenue | -6120.7% | -5234.4% |
| Capex IntensityCapex / Revenue | 40.1% | 1872.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-140.4M | $-117.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-78.6M | $-29.6M | ||
| Q3 25 | $-17.2M | $-25.2M | ||
| Q2 25 | $-19.2M | $-16.0M | ||
| Q1 25 | $-24.5M | $-9.5M | ||
| Q4 24 | — | $-6.3M | ||
| Q3 24 | $-16.1M | $-5.5M | ||
| Q2 24 | $-14.6M | $-5.7M | ||
| Q1 24 | $-21.9M | $-4.1M |
| Q4 25 | $-79.1M | $-46.1M | ||
| Q3 25 | $-17.4M | $-36.5M | ||
| Q2 25 | $-19.4M | $-22.0M | ||
| Q1 25 | $-24.6M | $-12.9M | ||
| Q4 24 | — | $-11.1M | ||
| Q3 24 | $-21.0M | $-10.1M | ||
| Q2 24 | $-20.6M | $-6.5M | ||
| Q1 24 | $-27.5M | $-4.1M |
| Q4 25 | -6120.7% | -5234.4% | ||
| Q3 25 | -1592.1% | -5314.1% | ||
| Q2 25 | -1326.6% | -3426.8% | ||
| Q1 25 | -963.6% | -2934.1% | ||
| Q4 24 | — | -6307.8% | ||
| Q3 24 | — | -4529.7% | ||
| Q2 24 | — | -1396.6% | ||
| Q1 24 | — | -431.1% |
| Q4 25 | 40.1% | 1872.1% | ||
| Q3 25 | 16.1% | 1649.6% | ||
| Q2 25 | 9.6% | 940.4% | ||
| Q1 25 | 4.7% | 785.7% | ||
| Q4 24 | — | 2755.1% | ||
| Q3 24 | — | 2070.7% | ||
| Q2 24 | — | 169.8% | ||
| Q1 24 | — | 0.4% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
